The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 27 | — | 20.1x | Below average | |
Growth | 42 | -25.0% | 5.6% | Near average | |
Quality | 37 | -135.8% | 7.6% | Near average | |
Safety | 24 | 1.0x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
VYNE Therapeutics Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy VYNE Therapeutics Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
VYNE stock shows a state of complete stability in price forecasts over the periods (last 1, 7, and 30 days), with the target price stabilizing at 5.75 dollars. This consistency reflects the absence of any recent revisions by analysts, noting that only one analyst currently covers the stock, which eliminates any Dispersion in estimates but simultaneously increases concentration risk and the limited analytical visibility of the stock.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.